Alsafadi S, Tourpin S, Bessoltane N, Salomé-Desnoulez S, Vassal G, André F, Ahomadegbe JC (2016) Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget 7:12331–12343. https://doi.org/10.18632/oncotarget.6329

Article  PubMed  Google Scholar 

Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR (2000) BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. Br J Cancer 82:436–440. https://doi.org/10.1054/bjoc.1999.0939

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Sun J, Ma J (2017) Proliferation and invasion of ovarian cancer cells are suppressed by knockdown of TRIM11. Oncol Lett. 14(2):2125–2130. https://doi.org/10.3892/ol.2017.6432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crawford LJ, Johnston CK, Irvine AE (2018) TRIM proteins in blood cancers. J Cell Commun Signal 12:21–29. https://doi.org/10.1007/s12079-017-0423-5

Article  PubMed  Google Scholar 

Dai W, Wang J, Wang Z, Xiao Y, Li J, Hong L, Pei M, Zhang J, Yang P, Wu X et al (2021) Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma. Front Oncol 11:767644. https://doi.org/10.3389/fonc.2021.767644

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng B, Zhang S, Zhang Y, Miao Y, Meng X, Guo K (2017) Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway. Neoplasma 64:893–900. https://doi.org/10.4149/neo_2017_611

Article  CAS  PubMed  Google Scholar 

Gilmore TD (1999) Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18:6925–6937. https://doi.org/10.1038/sj.onc.1203222

Article  CAS  PubMed  Google Scholar 

González-Martín A, Pothuri B, Vergote I, DePont CR, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G et al (2019) Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med 381:2391–2402. https://doi.org/10.1056/nejmoa1910962

Article  CAS  PubMed  Google Scholar 

Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA et al (2000) Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6:2104–2119

CAS  PubMed  Google Scholar 

Kawabata H, Azuma K, Ikeda K, Sugitani I, Kinowaki K, Fujii T, Osaki A, Saeki T, Horie-Inoue K, Inoue S (2017) TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling. Int J Mol Sci 18(9):1931. https://doi.org/10.3390/ijms18091931

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, Deretic V (2015) TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J Cell Biol 210:973–989. https://doi.org/10.1083/jcb.201503023

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimura T, Mandell M, Deretic V (2016) Precision autophagy directed by receptor regulators - emerging examples within the TRIM family. J Cell Sci 129:881–891. https://doi.org/10.1242/jcs.163758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koepke L, Gack MU, Sparrer KM (2021) The antiviral activities of TRIM proteins. Curr Opin Microbiol 59:50–57. https://doi.org/10.1016/j.mib.2020.07.005

Article  CAS  PubMed  Google Scholar 

Lai Y, Shen Y, Liu XH, Zhang Y, Zeng Y, Liu YF (2011) Interleukin-8 induces the endothelial cell migration through the activation of phosphoinositide 3-kinase-Rac1/RhoA pathway. Int J Biol Sci 7:782–791. https://doi.org/10.7150/ijbs.7.782

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Withoff S, Verma IM (2005) Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26:318–325. https://doi.org/10.1016/j.it.2005.04.003

Article  CAS  PubMed  Google Scholar 

Li CG, Hu H, Yang XJ, Huang CQ, Yu XQ (2019) TRIM44 Promotes Colorectal Cancer Proliferation, Migration, and Invasion Through the Akt/mTOR Signaling Pathway. Onco Targets Ther 12:10693–10701. https://doi.org/10.2147/ott.s228637

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Cui Z, Kong Y, Liu X, Wang X (2021) Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance. Biomed Res Int 2021:7341247. https://doi.org/10.1155/2021/7341247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Chen ZJ (2011) Expanding role of ubiquitination in NF-κB signaling. Cell Res 21:6–21

Article  PubMed  Google Scholar 

Liu S, Yin H, Ji H, Zhu J, Ma R (2018) Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer. Exp Ther Med 16:3034–3040. https://doi.org/10.3892/etm.2018.6541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Meng F, Ding J, Ji H, Lin M, Zhu J, Ma R (2019) High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer. Biosci Rep 39. https://doi.org/10.1042/bsr20181639

Luo Q, Lin H, Ye X, Huang J, Lu S, Xu L (2015) Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway. Int J Clin Oncol 20:508–517. https://doi.org/10.1007/s10147-014-0752-9

Article  CAS  PubMed  Google Scholar 

Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I et al (2016) Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med 375:2154–2164. https://doi.org/10.1056/nejmoa1611310

Article  CAS  PubMed  Google Scholar 

Mu HQ, He YH, Wang SB, Yang S, Wang YJ, Nan CJ, Bao YF, Xie QP, Chen YH (2020) MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Clin Transl Oncol 22:111–121. https://doi.org/10.1007/s12094-019-02217-5

Article  CAS  PubMed  Google Scholar 

Peng R, Zhang PF, Zhang C, Huang XY, Ding YB, Deng B, Bai DS, Xu YP (2018) Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Cancer Med 7:796–808. https://doi.org/10.1002/cam4.1313

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrera F, Meroni G (2012) TRIM proteins in development. Adv Exp Med Biol 770:131–141. https://doi.org/10.1007/978-1-4614-5398-7_10

Article  CAS  PubMed  Google Scholar 

Strozyk EA, Desch A, Poeppelmann B, Magnolo N, Wegener J, Huck V, Schneider SW (2014) Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation. Exp Dermatol 23:670–676. https://doi.org/10.1111/exd.12505

Article  CAS  PubMed  Google Scholar 

Sun J, Chen X, Ji X, Meng S, Wang W, Wang P, Bai J, Li Z, Chen Y (2022) TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer. Bioengineered 13:6024–6035. https://doi.org/10.1080/21655979.2022.2042134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venuto S, Merla G (2019) E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis. Cells 8. https://doi.org/10.3390/cells8050510

Wang X, Lv J, He B, Zhou D (2022) CircFBXW8 Acts an Oncogenic Role in the Malignant Progression of Non-small Cell Lung Carcinoma by miR-370–3p-Dependent Regulation of TRIM44. Biochem Genet 60:1313–1332. https://doi.org/10.1007/s10528-021-10177-1

Article  CAS  PubMed  Google Scholar 

Webb PM, Jordan SJ (2017) Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol 41:3–14. https://doi.org/10.1016/j.bpobgyn.2016.08.006

Article  PubMed  Google Scholar 

Yenmis G, YaprakSarac E, Besli N, Soydas T, Tastan C, DilekKancagi D, Yilanci M, Senol K, Karagulle OO, Ekmekci CG et al (2021) Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity. Acta Histochem 123:151709. https://doi.org/10.1016/j.acthis.2021.151709

Article  CAS  PubMed  Google Scholar 

Yi S, Liu G, Wu Y, Liang Q, Li L (2021) Baicalein suppresses the growth of the human thyroid cancer cells by inducing mitotic catastrophe, apoptosis and autophagy via NF-kB signalling pathway. J Buon 26:1180

PubMed  Google Scholar 

Yu XZ, Yuan JL, Ye H, Yi K, Qie MR, Hou MM (2021) TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK. Neoplasma 68:751–759

Article  CAS  PubMed  Google Scholar 

Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R et al (2016) High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumour Biol 37:14615–14628. https://doi.org/10.1007/s13277-016-5316-3

Article  CAS  PubMed